Philadelphia cell therapy startup launches with $250M in finanicial comitments
July 01, 2019 at 15:44 PM EDT
The company is using adult stem cell technology to develop new cell therapies that target hematologic and solid cancer tumors.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|